HACKENSACK, NJ / ACCESSWIRE / August 22, 2023 / Champions Oncology, Inc. (NASDAQ:CSBR), a global preclinical and clinical research services…
HAMBURG, GERMANY / ACCESSWIRE / August 22, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce…
Novel Nasal Spray for Traumatic Brain Injury Effects Poised to Demonstrate Efficacy in Patent-Pending ProductJACKSON CENTER, PA / ACCESSWIRE /…
The SOLACE Foundation to build awareness, promote prevention, and offer support to women who have experienced a severe obstetric laceration.BIRMINGHAM,…
New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancerSALT LAKE CITY,…
CARMEL, Ind., Aug. 22, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology…
Virtual Webinar to be held September 5, 2023, at 11:00 AM Eastern TimeAUSTIN, Texas, Aug. 22, 2023 (GLOBE NEWSWIRE) --…
CHICAGO, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) is offering a new international educational opportunity…
DALLAS, Aug. 22, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare’s (NYSE: AMN) mobile app, AMN Passport has surpassed 200,000 registered, ready-to-work…
Data demonstrated that ASH41020, a novel CSFR1 tyrosine kinase inhibitor ‘dendranib’, directs macrophage polarization toward the anti-inflammatory M2 phenotypeASH41020 treatment…